Foundation Medicine, Inc., a leader in precision medicine, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2010, the company has made significant strides in the oncology sector, focusing on genomic profiling to guide cancer treatment decisions. Foundation Medicine is renowned for its comprehensive genomic profiling services, including FoundationOne CDx and FoundationOne Liquid, which analyse tumour DNA to identify actionable mutations. These innovative products empower healthcare providers to tailor therapies to individual patients, setting the company apart in the competitive landscape of cancer diagnostics. With a strong market position, Foundation Medicine has achieved notable milestones, including partnerships with major pharmaceutical companies and integration into clinical practice guidelines, solidifying its reputation as a trusted resource in the fight against cancer.
We don't have data for Foundation Medicine, Inc., but we can show you information about their parent organization instead.
View parent company